Final Results of the Safety and Feasibility of Renal Venous Afterload Modulation with the Doraya in Acute Decompensated Heart Failure and Persistent Congestion

<p>Within the prior 24 months, I have had a financial relationship with a company producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients: </p><ul><li>Grant Support/Research Contract - Revamp Medical; Procyrion; Cardiosense; Edwards Lifesciences; WhiteSwell</li><li>Equity/Stock(s)/Options - Prospect Health</li></ul>